Severe mental illness is accompanied by cognitive fluctuations that can alter decision-making skills and lead to coerced care. Taking into account, on the one hand, the health, social and economic impact of forced hospitalization, on the other hand the importance of self-determination, the reinforcement of the power to act in the evolution of these disorders, new strategies to better reflect the views of people have been developed. Among these, the drafting of Advanced Directives in Psychiatric (ADP), allows people with mental disorders to write while their decision-making skills are restored care instructions in case of decompensation. It is a tool of "advanced therapeutic education" and early prevention of relapses. It is hypothesized that the implementation of drafting accompanied by advance directives to people with severe psychiatric disorders decreases in the short term the number of forced hospitalization care pathway of these people, compared to the subjects having not benefited from this device. This research will take the form of a randomized controlled trial on 3 sites. The "quantitative" evaluation component of results and processes will be completed with a qualitative anthropological and socio-political evaluation component documenting the trajectories of individuals and the implementation of the program, as well as a "participatory research" component aimed at a dialogue between users, researchers and professionals. The patient who is a beneficiary of the "Advanced Directives in Psychiatric" program will be encouraged to complete the " Advanced Directives in Psychiatric" document and will receive support in drafting them. The non-beneficiary patient of the program will follow up with his psychiatrist unchanged. The experimental design of the quantitative component is based on an experimental, randomized, prospective, controlled, parallel study, comparing two groups of subjects with severe psychiatric disorders. This research will assess the effectiveness, efficiency and impact of the " Advanced Directives in Psychiatric" program compared to conventional psychiatric care alone. Ultimately, the objective of describing the effects of the program on health organizations and on the representations and practices of professionals, caregivers and users is at the service of a better understanding of the conditions of possibility of the generalization of this experimentation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
399
The patient completes a questionnaire to express in advance his wishes regarding his future care in psychiatry.
standardized maintenance with the patient
Assistance Publique Hôpitaux de Marseille
Marseille, France
Rate of patients with compulsory admission
Evaluation of the hospitalization rate by comparing the two groups
Time frame: 12 months
Evaluation of patient recovery rates
The rate is assessed by the Recovery Assessment Scale (RAS)
Time frame: 12 months
Evaluation of the empowerment rate
The rate is assessed by the Empowerment Scale (ES)
Time frame: 12 months
Measuring the health-related quality of life of patients
Health-related quality of life is measured using a specific scale: the S-QOL. It is a self-reported instrument of 41 items that assesses the quality of life in patients with schizophrenia
Time frame: 12 months
Measuring mental health symptoms of patients
Mental health symptoms are measured by Modified Colorado Symptom Index (MCSI)
Time frame: 12 months
Evaluation of the therapeutic alliance between the patient and his psychiatrist
The therapeutic alliance between the patient and his psychiatrist is assessed by the 4-Point Alliance Self Report (4-PAS) questionnaire
Time frame: 12 months
Measuring Disease Awareness
Disease Awareness is assessed by the évaluée par l'échelle SUMD (Scale to Assess Unawareness in Mental Disorder
Time frame: 12 months
Evaluation of the severity of the psychiatric disorder by the psychiatrist
The severity of the psychiatric disorder is assessed by the Clinical Global Impression (ICG) scale
Time frame: 12 months
Medico-economic analysis (cost-utility)
Number of inpatient
Time frame: 12 months
Medico-economic analysis (cost-utility)
Number of emergency department visits
Time frame: 12 months
Medico-economic analysis (cost-utility)
Number of outpatient visits
Time frame: 12 months
Medico-economic analysis (cost-utility)
Loss of productivity
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.